EMEA-000662-PIP02-09-M05 - paediatric investigation plan
Decision type: RPM: decision refers to a refusal on the application for modification of an agreed PIP
Therapeutic area: Pneumology-allergology
PIP number: P/0548/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000838-PIP01-10-M02 - paediatric investigation plan
Decision type: RPM: decision refers to a refusal on the application for modification of an agreed PIP
Therapeutic area: Pneumology-allergology
PIP number: P/0526/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ronaxan and its associated names - referral
Doxycycline
Article 34
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralVeterinary
EMEA-000808-PIP01-09-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Pneumology-allergology
PIP number: P/224/2019
Route(s) of administration: Sublingual use
Pharmaceutical form(s):
Oromucosal solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Doxyprex 100mg Premix - referral
Doxycycline
Article 33
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralVeterinary
EMEA-000945-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: P/320/2010
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000955-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: P/326/2010
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000941-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: P/316/2010
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000958-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: P/329/2010
Route(s) of administration: Sublingual use
Pharmaceutical form(s):
Oral solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000944-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: P/319/2010
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman